Cowen & Company Initiates Coverage on Reata Pharmaceuticals to Outperform

Cowen & Company Initiates Coverage on Reata Pharmaceuticals(NASDAQ:RETA). The shares have been rated Outperform. The rating by Cowen & Company was issued on Jun 20, 2016.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *